X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Glenmark Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Glenmark Pharma Quarterly Results   (GLPH)

Here are the latest quarterly results of Glenmark Pharma. For more details, see the Glenmark Pharma financial fact sheet and Glenmark Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Glenmark Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-16
*
3
Dec-16
*
3
Mar-17
*
3
Jun-17
*
3
Sep-17
*
3
Dec-17
*
3
Mar-18
*
3
Jun-18
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m22,24125,35024,57223,63022,56622,03722,79821,656 
Other income Rs m18146513153297-2326961,382 
Turnover Rs m22,25925,49625,08523,78322,86321,80523,49423,038 
Expenses Rs m17,75317,70020,13317,85618,68218,81019,53018,187 
Gross profit Rs m4,4517,6502,6035,7743,8843,2273,2683,469 
Depreciation Rs m687625689777752754735794 
Interest Rs m629617697709698705744790 
Profit before tax Rs m3,1546,5531,7304,4412,7311,5372,4853,267 
Tax Rs m9181,7821071,108589489968937 
Profit after tax Rs m2,2364,7701,6233,3342,1411,0471,5162,330 
Gross profit margin %20.030.210.624.417.214.614.316.0 
Effective tax rate %29.127.26.224.921.631.839.028.7 
Net profit margin %10.118.86.614.19.54.86.710.8 
Diluted EPS Rs 8.2 17.6 6.0 12.3 7.9 3.9 5.6 8.6  
Diluted EPS (TTM) Rs 29.2 40.5 40.2 44.1 43.7 30.0 29.6 25.9  
 Subscriber Feature View View View   View        
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Glenmark Pharma 1QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   PFIZER  NATCO PHARMA  FRESENIUS KABI ONCO.  STRIDES SHASUN LTD  MERCK LTD  

Compare GLENMARK PHARMA With:   PFIZER  NATCO PHARMA  FRESENIUS KABI ONCO.  STRIDES SHASUN LTD  MERCK LTD  

Compare GLENMARK PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 132 Points Higher; IT and Healthcare Stocks Witness Buying(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed buying interest during the closing hours and ended the day in green.

Views on news

GLENMARK PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Sep 27, 2018 | Updated on Sep 27, 2018

Here's an analysis of the annual report of GLENMARK PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

GLENMARK PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 30.1% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, GLENMARK PHARMA has posted a net profit of Rs 2 bn (down 30.1% YoY). Sales on the other hand came in at Rs 22 bn (down 8.4% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (4QFY18); Net Profit Down 6.6% (Quarterly Result Update)

May 31, 2018 | Updated on May 31, 2018

For the quarter ended March 2018, GLENMARK PHARMA has posted a net profit of Rs 2 bn (down 6.6% YoY). Sales on the other hand came in at Rs 23 bn (down 7.2% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Don't Panic in This Falling Market... Do This Instead(The 5 Minute Wrapup)

Oct 5, 2018

Find companies with long term durable moats, which are correcting with the current broader market sell-off.

Why You Should Be Excited, Not Sad, About the 30% Small Cap Crash(Profit Hunter)

Oct 4, 2018

Smallcaps have corrected over 30% since the beginning of the year. Find out why Richa Agarwal views this as an opportunity rather than a threat.

Taxpayers to pay salaries of CEOs/CIOs of Mutual Funds(The Honest Truth)

Oct 5, 2018

Ajit Dayal on the crisis in the market and in the mutual fund industry.

Why Are Investors In Sundaram Small Cap Fund Anxious(Outside View)

Oct 3, 2018

A small cap fund that aims to capitalise on emerging businesses and catch them young. However, its failure in keeping volatility under check is making its investors anxious.

Biggest Corrections in the Stock of Infibeam Avenues(Chart Of The Day)

Oct 3, 2018

Infibeam plunged over 70% last week. This was the second biggest single-day fall. But Infibeam witnessed such sharp falls earlier.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GLENMARK PHARMA SHARE PRICE


Oct 15, 2018 (Close)

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA - MERCK LTD COMPARISON

COMPARE GLENMARK PHARMA WITH

MARKET STATS